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EBV-Infected B Cells in Infectious
Mononucleosis: Viral Strategies for Spreading
in the B Cell Compartment and Establishing Latency
(Miyashita et al., 1997; Babcock et al., 2000 [this issue
of Immunity]). In this way a balance between rare EBV-
harboring B cells (one in 105–106 peripheral B cells
[Wagner et al., 1992; Miyashita et al., 1995]) and EBV-
specific T cells is established during persistence of the
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multinucleated cells that resemble morphologically and60590 Frankfurt
by the expression of CD30 Hodgkin and Reed-SternbergGermany
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cells vary not only in their morphology but also showGermany
different expression patterns of EBV-encoded genes.kAllina Laboratories
These expression patterns are consistent with the threeMinneapolis, Minnesota 55407
classical programs of EBV gene expression (Rickinson
and Kieff, 1996). Three classes of cells can be distin-
guished: (1) cells, mostly of small size, expressing EBERSummary
transcripts but neither LMP1 and LMP2A nor EBNA2
(latency I); (2) lymphoblasts and HRS-like cells express-Infection of humans with Epstein-Barr virus (EBV) may
ing EBER transcripts, LMP1, and LMP2A but not EBNA2cause infectious mononucleosis (IM). Analysis of sin-
(latency II); and (3) small- to medium-sized cells andgle EBV-infected cells from tonsils of IM patients for
some HRS-like cells positive for EBER transcripts,rearranged immunoglobulin genes revealed two strat-
LMP1, LMP2A, and EBNA2 (latency III) (Niedobitek etegies of EBV for rapid and massive spread in the B
al., 1997a, 1997b; unpublished data). While, at least latecell compartment: the direct infection of many naive
after infection, most if not all EBV-bearing cells repre-as well as memory and/or germinal center B cells and
sent B cells, T cells and epithelial cells may initially alsothe expansion of the latter cells to large clones. In IM,
harbor EBV (Sixbey et al., 1984; Tokunaga et al., 1993;the generation of virus-harboring memory B cells from
Anagnostopoulos et al., 1995).naive B cells passing through a germinal center reac-
In addition to the mentioned classical terminology oftion likely plays no role. Members of clones can show
latent EBV gene expression, another nomenclature ofdistinct morphologies and likely also EBV gene ex-
EBV latency programs has been developed based on thepression patterns, and this ability implies a mechanism
behavior of the virus in normal B cells during persistentby which EBV-harboring cells can evade immune
infection in vivo (Thorley-Lawson et al., 1996; Babcocksurveillance and establish a pool of persisting EBV-
et al., 2000). According to this hypothesis, EBV infectsinfected B cells.
in tonsils naive IgD1 B cells, which are driven into prolif-
eration and express all EBV-encoded latent genesIntroduction
(growth program, classical latency III). The virus gains
access to the compartment of memory B cells, as these
Epstein-Barr virus (EBV) is a ubiquitous, tumorigenic
EBV-bearing naive B cells proceed in differentiation like
herpes virus infecting more than 90% of the human noninfected B cells; in T cell–dependent antibody re-
population (Rickinson and Kieff, 1996). During child- sponses, antigen binding cells are activated by antigen
hood, primary infection by EBV is usually asymptomatic and T helper cells and are driven into the germinal center
and leads to a lifelong persistence of the virus. Primary (GC) reaction, where mutations are introduced into their
infection in adolescents and young adults can cause rearranged V region genes in the course of cellular prolif-
infectious mononucleosis (IM), a self-limiting, lympho- eration (Rajewsky, 1996). Mutant cells expressing anti-
proliferative disease (Henle et al., 1968). In the course gen receptors with high affinity for the immunizing anti-
of the disease, one in 104 circulating B cells is infected gen subsequently differentiate into plasma cells or are
by EBV (Tosato et al., 1984; Rocchi et al., 1977). In selected into the pool of long-lived, recirculating mem-
response to spreading of EBV, there is a massive prolif- ory cells. During this differentiation process, EBV-bear-
eration of T cells, including EBV-specific cytotoxic T ing cells change the expression pattern of EBV-encoded
cells (Callan et al., 1996, 1998), which eliminate most genes. GC centroblasts and centrocytes as well as reac-
EBV-infected cells. However, some resting EBV-infected tivated memory B cells express EBNA1, LMP1, and
B cells lacking expression of most or all EBV-encoded LMP2A (classical latency II). Resting recirculating mem-
immunogenic proteins can evade immune surveillance ory B cells show another type of latency, which ensures
escape from immune surveillance. This program is char-
acterized by expression of EBER transcripts and per-# To whom correspondence should be addressed (e-mail: jkurth@
mac.genetik.uni-koeln.de). haps LMP2A and EBNA1 (latency program) (Qu and
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Rowe, 1992; Tierney et al., 1994; Chen et al., 1995; Mi-
yashita et al., 1997; Babcock et al., 2000).
EBV is associated with malignancies such as Burkitt’s
lymphoma, posttransplantation lymphoproliferative dis-
orders, nasopharyngeal carcinoma, and rare T cell lym-
phomas (Rickinson and Kieff, 1996). A role of EBV has
also been suggested in the pathogenesis of HD because
HRS cells, the malignant cells of HD, carry clonal copies
of EBV in about 50% of the cases (Rickinson and Kieff,
1996). A potential association between HD and IM is
implied from the observation that patients with a history
of IM have a 3- to 4-fold increased risk of developing
HD (Rosdahl et al., 1974; Munoz et al., 1978). In a fraction
of classical HD cases, the HRS cells carry “crippling”
mutations that render originally productive V region
genes nonfunctional (Kanzler et al., 1996; Ku¨ppers and
Rajewsky, 1998). Since loss of B cell receptor expression
in GC B cells normally results in cell death by apoptosis,
HRS cells, at least in these cases, thus appear to be
derived from “crippled” GC B cells that were rescued
from apoptosis through some transforming event (Kanz-
ler et al., 1996; Ku¨ppers and Rajewsky, 1998). In EBV-
positive cases of HD, this initial transforming event might
be infection by EBV and subsequent expression of
LMP2A, the viral oncogene LMP1, or both (Kanzler et
al., 1996; Caldwell et al., 1998; Kulwichit et al., 1998).
It is still unknown how EBV establishes the pool of
EBV-carrying cells during acute infection and persis-
tence. Moreover, a possible relationship between HRS-
like cells of IM and the malignant cells of HD in terms
of their cellular derivation remains elusive. To approach
these questions, we micromanipulated single, morpho-
logically and phenotypically distinct EBV-infected cells
from frozen tissue sections of two cases of IM and ana-
lyzed them for immunoglobulin V gene rearrangements.
This allowed us to characterize the composition of the
EBV-harboring B cell population in terms of clonality and
stage of differentiation and thus to trace the pathway of
viral spread in the B cell compartment.
Results
Figure 1. Phenotypic Characterization of EBV-Infected Cells
Stainings were performed on tonsillar sections.Histological Distribution of EBV-Infected Cells
(A) Overview of a paraffin section of case 1 stained for EBER tran-Tonsillar sections of six cases of IM were stained for
scripts (red staining). A part of one region with EBV-infected cellsEBER transcripts or CD30 expression in order to define
is shown.the localization of EBV-infected cells and HRS-like cells
(B) Overview of a frozen section of case 2 stained for EBER tran-
in the tissue. Besides their mainly interfollicular location scripts (blue-purple staining). The dissemination of EBV-bearing
often adjacent to crypt epithelium (the entry site of EBV cells is shown.
(C) Overview of a paraffin section of case 1 stained for EBER tran-into the tonsil) and areas of necrosis, it became evident
scripts (red staining). The phenotypic variation of EBV-infected cellsthat EBV-positive cells in five of the six cases are re-
is shown.stricted to some interfollicular regions (Figure 1A; data
(D) Paraffin section of case 1 stained for EBER transcripts (rednot shown). In only one case were most EBV-harboring
staining); small EBV-infected cells are shown.
cells evenly distributed throughout the tissue section (E) Frozen section of case 2 stained for EBNA2 (brown staining)
(Figure 1B). (F) Paraffin section of case 1 stained for LMP1 (brown staining)
(G) HRS-like cells from a frozen section of case 1 stained for CD30In addition, tonsillar sections of five of the six patients
(red staining).with IM were stained for expression of LMP1 in combina-
(H) Frozen section of case 2 stained for LMP1 (red fluorescent stain-tion with EBNA2 protein or for EBER transcripts (in three
ing) and EBNA2 (green fluorescent staining).cases in combination with CD30) (Figure 1; data not
shown). By means of these double stainings and based
on the assumption that all EBV-infected cells are posi- cells express EBER transcripts but not LMP1 and
EBNA2 (latency program or classical latency I; mainlytive for EBER transcripts, EBV-harboring cells can be
divided into the following phenotypically different sub- small- to medium-sized CD302 cells); (2) 20%–30% of
cells express EBER transcripts and LMP1 but nottypes (see also Introduction): (1) fewer than 10% of
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EBNA2 (classical latency II; mononucleated [occasion-
ally CD301] lymphoblasts and large, often multinucle-
ated CD301 HRS-like cells, sometimes with irregularly
shaped nuclei); and (3) 10%–20% of cells express EBER
transcripts, LMP1, and EBNA2 (classical latency III;
small- to medium-sized CD302 cells and, rarely, CD301
HRS-like cells). In addition, 50%–60% of EBER1 cells
(or perhaps somewhat fewer if cells with single dots of
LMP1 signal are regarded as LMP1 positive) are small-
to medium-sized cells expressing EBNA2 but not LMP1.
This might represent a transitory stage shortly after in-
fection since in newly infected B cells expression of
EBNA2 precedes expression of LMP1 (Alfieri et al., 1991;
Niedobitek et al., 1997a) (Figure 1). Between 1% and
5% of EBV-bearing cells acquire an HRS-cell like mor-
phology.
PCR Analysis of Isolated EBV-Infected Cells
EBV-infected cells of two of the six cases of IM were
analyzed at the molecular level. These two cases differ
on the one hand by the time of tonsillectomy in the
course of the disease (case 1, 3 days after onset of symp-
toms; case 2, more than 14 days after onset of symp-
toms) and on the other hand by the distribution of EBV-
harboring cells. As with most tonsils analyzed, the first
case showed local restriction of EBV-infected cells (see
above); in this biopsy four areas with EBV-carrying cells
were identified (Figures 1A and 2A). In the second case,
EBV-bearing cells were found throughout the tissue (Fig-
Figure 2. Diagrammatic Representation of Tonsillar Sections of the
ures 1B and 2B). Two Analyzed Cases of IM Indicates the Distribution of Clonally
Besides gaining insight into the overall composition Related Cells
of EBV-harboring cell populations in terms of clonality Regions where EBV-infected cells are mainly located are shown in
and differentiation stage, we were also interested in the gray. The location of cells with unique V gene rearrangements is
not shown.nature of the cells positive for LMP1 or EBNA2. These
(A) Case 1: in this case EBV-harboring cells are predominantly foundsubsets of EBV-infected cells were included in the analy-
in the four regions indicated. The clone number, the number ofsis since we wanted to find out whether distinct subsets
members, and the location of the clones are indicated in boxes.
of EBV-bearing cells (with regard to clonal composition Clonally related cells were found evenly distributed inside the re-
and stage of development) can be defined by these spective regions.
markers. For example, it has been speculated that (B) Case 2: EBV-infected cells are evenly distributed throughout the
section. Individual members of a given clone are marked with theEBNA2 expression is restricted to naive EBV1 B cells
same symbol.(Babcock et al., 2000). In addition, HRS-like cells were
analyzed in order to study their possible relationship to
HRS cells in HD. Therefore, for the first case, EBER1
cells, some cells were analyzed in parallel for the pres-cells (representing the overall population of EBV-infected
ence of a fragment of the EBV-encoded EBNA1 gene.cells), LMP11 cells (representing cells in latency II or III),
In both cases, the EBNA1-specific PCR product couldand EBNA21 cells (representing cells in latency III and/
be amplified from the vast majority of cells positive foror newly infected cells) were isolated (Figure 1; for mor-
V gene rearrangements, and this fact demonstrated thatphological and immunophenotypic criteria of cell isola-
the cells are indeed infected by the virus (Table 2). Sin-tion see Table 1). In addition, HRS-like cells were micro-
gle micromanipulated CD31 T cells, EBER2 cells, andmanipulated (Figure 1G; Table 1). For the second case,
CD201 B cells as well as aliquots of the buffer coveringsmall- to medium-sized EBV-infected cells were micro-
the sections during micromanipulation served as con-manipulated from sections stained for both CD30 and
trols. In both cases PCR products for rearranged VEBER transcripts. This staining allowed us to isolate
genes or the fragment of the EBNA1 gene were amplifiedcells of the main population of EBV-bearing cells
only very rarely from negative controls. They probably(CD302, EBER1 cells) and to exclude the rare CD301
result from contaminated fragments of B cells or EBV-HRS-like cells (Table 1). The latter cells were micro-
infected cells (Table 2).manipulated from CD30-stained sections (Figure 1G; Ta-
ble 1). In addition, EBNA21 cells were isolated (Figure
1E; Table 1). Naive as Well as Memory and/or GC B Cells
Are Infected by EBVThese isolated single cells were analyzed by PCR for
VH and Vl gene rearrangements (Table 2) (Vk genes were From the first case, 224 V gene rearrangements were
amplified from 203 of 698 cells analyzed, and from thenot analyzed, for reasons outlined in the Experimental
Procedures). In order to confirm EBV infection of the second case, 79 V gene rearrangements were amplified
Immunity
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Table 1. Cell Types Analyzed
Morphological Criteria Immunophenotypic Criteriaa
Case Isolated Subset Cell Type for the Isolation of Cells for the Isolation of Cells
1 EBER1 overall population of EBV-infected cells — EBER1 or CD302 EBER1b
EBNA21 cells in latency III or newly infected cells — EBNA21
LMP11 cells in latency II or III — LMP11
HRS-like HRS-like cells large, often multinucleated CD301 or CD301 EBER1
irregularly shaped nucleus
2 EBER1 overall population of EBV-infected cells small- to medium-sized CD302 EBER1
excluding HRS-like cells
EBNA21 cells in latency III or newly infected cells — EBNA21
HRS-like HRS-like cells large, often multinucleated, CD301
irregularly shaped nucleus
a Including in situ hybridization for EBER transcripts.
b From the CD30 and EBER double staining only small CD302 EBER1 cells were isolated (approximately 30% of the total number of EBER1
cells).
from 67 of 367 cells analyzed (Tables 2 and 3). The may be due to technical matters such as DNA instability
during handling of sections, or it may indicate that somerelatively low amplification efficiency for some of these
populations (e.g., 20 V gene rearrangements were ampli- of the EBV-infected cells are not B but T cells (Tokunaga
et al., 1993; Anagnostopoulos et al., 1995). However,fied from 120 EBNA21 cells from case 1; see Table 2)
Table 2. Summary of the Single-Cell Analysis from Two Cases of IM
Number of
Number of EBNA1-PositiveGene Rearrangements
Number of Cells/ Samples per VH and/or Vl-Positive
Case Cell Type Samples Analyzeda VH Vl Cells Analyzedb
1 All 698 224 90/95
EBER1 176d 60e 6 52/56
EBNA21 120 20 n.d. n.d.
LMP11 142 36 6 3/3
HRS-like 260d 72e 24 35/36
2 All 367 79 49/54
EBER1 100 20 8 26/26
EBNA21 140 13 n.d. n.d.
HRS-like 117 31 7 23/28
Controls
1 B cellsc 39 11 5 n.d.
EBER2
c
47 n.d. n.d. 0/47
T cells 35 1 0 0/20
Buffer 210d 3f 1 0/110
2 B cells 50 11 4f 14/50
EBER2 33 n.d. n.d. 1/33
T cells 121d 6 3f 6/71g
Buffer 121d 1 0 1/79
a The following PCR analyses were carried out: (1) 96 EBER1 cells, 37 LMP11 cells, 22 HRS-like cells, 47 EBER2 cells, one T cell and 41 buffer
controls of the first case and 80 EBER1 cells, 70 HRS-like cells, 45 B cells, 25 EBER2 cells, 47 T cells, and 54 buffer controls of the second
case were analyzed after preamplification with a combination of VH/Vl and EBNA1 primers; (2) 50 EBER1 cells, 50 HRS-like cells, and 35 buffer
controls of the first case were analyzed after preamplification with a combination of VH and EBNA1 primers; (3) 91 HRS-like cells, 19 T cells,
and 34 buffer controls of the first case and 20 EBER1 cells, five B cells, eight EBER2 cells, six T cells and six buffer controls of the second
case were analyzed with a combination of VH/Vl and EBNA1 primers; (4) 47 HRS-like cells, 18 T cells, and 19 buffer controls of the second
case were analyzed with a combination of VHL/Vl and EBNA1 primers; (5) 30 EBER1 cells, 105 LMP11 cells, 97 HRS-like cells, 39 B cells, 15
T cells, and 61 buffer controls of the first case were analyzed with a combination of VH and Vl primers; (6) 120 EBNA21 cells and 39 buffer
controls of the first case were analyzed with VH primers, (7) 140 EBNA21 cells, 50 T cells, and 42 buffer controls of the second case were
analyzed after preamplification with VH primers.
b For controls, all analyzed samples are considered.
c One to three CD201 B cells or EBER2 cells were transferred into one tube; altogether 39 B cells and 47 EBER2 cells were analyzed.
d 126 EBER1 cells, 273 HRS-like cells, 136 buffer controls of case 1 and 71 T cells and 79 buffer controls of case 2 were analyzed for Vl gene
rearrangements (in addition to VH rearrangements).
e Two double sequences are not considered.
f One sequence is identical to a clonal VH3 rearrangement obtained from 22 cells; all other rearrangements from control cells were not clonally
related to sequences from HRS-like cells or other EBV-infected cells. One Vl1 rearrangement amplified from a T cell is identical to a
rearrangement obtained from a CD201 B cell.
g The amplification of fragments of the EBNA1 gene from 6 of 71 T cells analyzed is compatible with infection of T cells.
HRS-like cells and other EBV-infected cells were analyzed together with T cells, B cells, EBER2 cells, and aliquots of buffer covering the
sections during micromanipulation.
EBV-Infected B Cells in Infectious Mononucleosis
489
Table 3. Sequence Analysis of Ig Gene Rearrangements Amplified from Single EBV-Infected Cells of Two Cases of IM
Average Mutation Frequency
Percent of Cells Number of Clones of Gene Rearrangementsb
Number of with Mutated V Gene Percent of Cells with Mutated V Gene
Case Cell Type Cells Positive Rearrangements Belonging to Clonesa Rearrangements VH Vl
1 All cells 203 96 78 20/20 6.3 3.9
EBER1 64 97 86 7.9 6.0e
EBNA21 19 100 74 4.8
LMP11 33 91 61 5.5 5.4e
HRS-like 87 95 79 5.7 3.2
2 All cells 67c 85 32 8/8d 6.1 2.6
EBER1 26 81 50 5.2 2.2
EBNA21 13 92 0e 5.7
HRS-like 28c 85 27 6.8 3.1
a The following clones are composed of phenotypically distinct members: clone 2 of case 1: 23 small- to medium-sized EBV-infected cells
(12 CD302 EBER1 cells, ten EBNA21 cells, one LMP11 cell) and 22 HRS-like cells (eight CD301, eight LMP11 and six CD301 EBER1 HRS-
like cells); clone 3 of case 1: five small- to medium-sized cells (three EBNA21 cells and two LMP11 cells) and 11 HRS-like cells (six CD301,
three LMP11 and two CD301 EBER1 HRS-like cells); clone 4 of case 1: 1 small CD302 EBER1 cell and 11 HRS-like cells (seven CD301 and
four CD301 EBER1 HRS-like cells); clone 5 of case 1: three small- to medium-sized cells (one CD302 EBER1 cell and two LMP11 cells) and
two HRS-like cells (one CD301 and one CD301 EBER1 HRS-like cells); clone 7 of case 1: six small- to medium-sized cells (five EBER1 cells
and one LMP11 cell) and one CD301 HRS-like cell; clone 20 of case 1: one small EBNA21 cell and one CD301 EBER1 HRS-like cell; clone 1
of case 2: four small- to medium-sized CD302 EBER1 cells and one HRS-like cell; clone 3 of case 2: one small- to medium-sized CD302
EBER1 cell and two HRS-like cells.
b Considering only mutated V gene rearrangements.
c From two samples both a mutated and an unmutated in-frame VH region gene were amplified. This indicated the presence of (fragments of)
two B cells in these tubes. These samples were not further taken into consideration.
d One “mutated” clone is defined by four members with unmutated V gene rearrangements and two members with two and three mutations
each. In addition, for one of the clones classified as “mutated” this assignment is uncertain since the two members of this clone harbor only
a single shared nucleotide difference to the most homologous known germline gene, which may represent a polymorphism. Moreover, since
this clone is defined by a Vl gene rearranged without N-sequences to Jl6, it cannot be excluded that these two rearrangements are derived
from two clonally independent cells.
e These values are considered not to be significantly different from the corresponding values obtained from other cellular subsets due to the
low number of sequences.
since no EBNA21CD31 T cells could be identified in From case 2, 85% of cells carry somatically mutated
V gene rearrangements with average mutation frequen-any of four cases of IM that were analyzed for cells
simultaneously expressing CD3 and EBNA2 (data not cies of 6.1% and 2.6% for mutated VH and Vl gene
rearrangements, respectively (Table 3). No significantshown) and since the amplification efficiency in the
present study is largely within the range typical for the differences with regard to the fraction of mutated cells
and the mutation frequencies were observed betweenamplification of Ig gene rearrangements from single,
micromanipulated B cells (Ku¨ppers et al., 1993), most the three distinct populations of cells analyzed. Thus,
in this case of IM as well, B cells of different stages ofEBV-harboring cells and especially EBNA2-expressing
cells are likely B cells. development are infected by EBV.
The ratio of replacement to silent mutations (R/SIn case 1, sequence analysis of VH and Vl gene re-
arrangements revealed that 96% of the cells carry so- value) in framework regions (FRs) of productive V gene
rearrangements can be taken as a sign for selection ofmatically mutated V region genes, while 4% are charac-
terized by unmutated V gene rearrangements. The the respective B cells for antigen receptor expression.
The intrinsic R/S value for random mutagenesis withoutaverage mutation frequency of mutated VH and Vl region
genes was 6.3% and 3.9%, respectively (Table 3). These selection (as in out-of-frame rearrangements) is usually
about 3 (Klein et al., 1998a). After selection within GCs,values are typical for GC or memory B cells (Goossens
et al., 1998; Klein et al., 1998b). The fraction of cells with cells are characterized by lower R/S values because R
mutations are usually counterselected within FRs. Themutated V genes and the average mutation frequencies
were similar for the subtypes of EBV-infected cells (Ta- average R/S value in FRs of the productive V gene re-
arrangements analyzed here (1.7 in both cases analyzed;ble 3). Hence, two distinct populations of EBV-infected
cells were identified: (1) a small number of cells carrying clonally related cells counted only once) is in between
the R/S values typical for selected memory B cells (1.0–unmutated V region genes and likely representing naive
B cells and/or recent GC immigrants that have not yet 1.6) and the average R/S value of GC centroblasts (1.8),
which are not yet fully selected for expression of a high-acquired somatic mutations and (2) a main population
of cells having mutated V gene rearrangements and rep- affinity antigen receptor (Klein et al., 1998a).
resenting memory and/or GC B cells. Although at the
time of their isolation the EBV-bearing cells were not Clonal Expansion of EBV-Infected Cells
In the first case, 78% of the cells from which V genelocated inside GCs, the possibility that (some of) these
cells had been infected inside GCs has to be taken into rearrangements were amplified could be assigned to 20
clones with 2–45 members (Table 3; Figure 2A). Theseconsideration because tonsillar GCs often vanish during
the course of IM. clones are characterized by the following features: (1)
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members of a given clone are locally restricted to one by 23 small EBV1 cells (micromanipulated from sections
stained for EBER transcripts, LMP1, or EBNA2) and 22of the four regions where EBV-infected cells were pre-
dominantly found; (2) with the exception of few nucleo- HRS-like cells (see legend to Table 3 for composition
of the clones). In the first case, the number of clonestide exchanges (two V gene rearrangements with one
difference each among approximately 40,000 bp V gene with phenotypically distinct members is most likely un-
derestimated since HRS-like cells and small CD302,sequence amplified from 172 V genes of clonally related
cells), which are likely due to Taq DNA polymerase errors EBER1 cells were mainly micromanipulated from differ-
ent regions.or rare spontaneous somatic mutation, no intraclonal
sequence diversity was observed among clonally re-
lated rearrangements; and (3) V gene rearrangements Comparison between HRS-like Cells of IM
of all clones are somatically mutated (average mutation and HRS Cells of Classical HD
frequency of VH and Vl gene rearrangements: 7.2% and In cases of B cell–derived classical HD, HRS cells are
4.6%, respectively). This mutation frequency is compa- a clonal population of mature B cells characterized by
rable to that of the general population of EBV-bearing mutated V gene rearrangements (average mutation fre-
cells. Consequently, the preferential clonal expansion quency of VH gene rearrangements: 11.2%), an average
of memory and/or GC B cells results in an overrepresen- R/S value in FRs of productive V gene rearrangements of
tation of these cells among EBV-carrying cells (if clonally 1.7, and obviously crippling mutations such as nonsense
related cells are counted only once, 86% of the cells mutations in potentially functional V gene rearrange-
belong to the memory and/or GC B cell compartment, ments in approximately 30% of the cases (Klein et al.,
as compared to 96% if all cells are counted individually). 1998a; Ku¨ppers and Rajewsky, 1998). In comparison, the
Taken together, EBV-infected memory and/or GC B cells R/S value in FRs of productive rearrangements amplified
expand in a locally restricted manner without undergo- from HRS-like cells in IM (1.6) resembles that of HRS
ing (further) somatic hypermutation. cells in HD, while the average mutation frequency of
In the second case of IM, eight clones with 2–6 mem- mutated VH gene rearrangements is lower (6.9%; clonally
bers were identified (Figure 2B). Although EBV-bearing related cells were considered only once here and below).
cells were disseminated throughout the tissue in this In contrast to HRS cells of HD, HRS-like cells of IM do
case, the distribution of clonally related cells was also not represent a single clone, and 14% of these cells carry
locally restricted (Figure 2B). In comparison to the first unmutated V region genes. Furthermore, no crippling
case, a lower fraction of cells (32%) could be assigned mutations were observed among mutated, potentially
to clones (Table 3). Clone 1 consists of four members functional V gene rearrangements amplified from more
with unmutated V gene rearrangements and two mem- than 50 HRS-like cells of IM.
bers with two and three mutations, respectively. Hence,
this clone might represent an expanding GC founder B Discussion
cell that started mutating the V gene rearrangements
upon proliferation (Lebecque et al., 1997). Since the EBV Infection of Naive as Well as Memory
other seven clones also have mutated V gene re- and/or GC B Cells
arrangements, there seems to be a preferential clonal Although it has been known since 1968 that EBV causes
expansion of memory and/or GC B cells in the second IM (Henle et al., 1968), we still know remarkably little
case, as well. However, occasional proliferation of naive about the cellular target(s) of the virus in vivo. The deriva-
B cells after infection by EBV in vivo cannot be excluded tion of EBV-infected cells in IM has been analyzed by
(see legend to Table 3). In case 2, cells belonging to immunohistochemistry and in situ hybridization. Most
clones with mutated V gene rearrangements are charac- of these studies showed that EBV-harboring cells and
terized by an average mutation frequency of 6.3% for especially HRS-like cells are mainly B cells (Isaacson et
their VH genes, and this frequency is similar to that of al., 1992; Reynolds et al., 1995; Niedobitek et al., 1997a).
the overall population of EBV-infected memory B cells In the two cases of IM investigated here, many EBV-
(Table 3; the average mutation load of three mutated Vl infected cells and HRS-like cells were also identified as
genes is 1.5%). No intraclonal diversity (with the excep- B cells.
tion of the five nucleotide exchanges in clone 1) was Sequence analysis of V region genes amplified from
observed among members of clones. If both cases are EBV-infected B cells shows that cells with unmutated
taken together, most if not all large clones seem to be as well as mutated V genes are infected. The latter con-
derived from EBV-bearing memory and/or GC B cells, stitute 86% and 89% of the cells in the two cases investi-
which proliferate largely without ongoing somatic hyper- gated (clonally related cells count only once). Cells with
mutation. In addition, members of clones are located in unmutated V gene rearrangements likely represent na-
proximity to each other. ive, antigen-unexperienced cells or derive from the small
population of GC founder cells, which were not yet tar-
geted by somatic hypermutation (Lebecque et al., 1997).Phenotypic Variations within Clones
of EBV-Infected B Cells On the basis of the present study, one can speculate
about the derivation of EBV-infected cells with mutatedThe identification of clones of EBV-harboring cells in
the present study allowed us to address the question V gene rearrangements. According to the scenario pro-
posed by Babcock et al. (1998) for virus persistenceof whether clonally related EBV-positive cells can show
distinct morphology. Eight clones isolated from the two resulting from asymptomatic infection, the pool of EBV-
infected cells with mutated V gene rearrangements mightpatients are composed of phenotypically distinct mem-
bers. For example, clone 2 of the first case is defined be formed by infection of naive cells, which are driven
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into a GC reaction after infection and EBV-induced pro- Whereas all of the 20 clones identified in case 1 and
all of the eight clones of case 2 (with one potentialliferation. These cells might then acquire somatic muta-
tions within their V region genes and differentiate to exception) are derived from memory or GC B cells, a
fraction of EBV-infected cells not assigned to clonesmemory B cells (Babcock et al., 1998). If this scenario
also holds true for IM, then one would expect to find likely represents naive B cells. Hence, for unknown rea-
sons, there seems to be a preferential expansion ormembers of clones that show extensive intraclonal V
gene diversity due to somatic hypermutation during pro- survival of EBV-carrying memory and/or GC B cells in
IM. The latter may be induced by EBV to differentiateliferation inside the GC. However, among 173 cells be-
longing to 27 clones, only a single clone shows some into memory B cell–like cells. The overrepresentation of
EBV-infected cells of a memory phenotype (which areintraclonal diversity. Hence (with rare exceptions), EBV-
infected B cells proliferate without undergoing somatic presumably long-lived) might be an important aspect
of the viral strategy to establish a lifelong persistencehypermutation. Consequently, it is unlikely that in IM the
pool of EBV-carrying B cells with mutated V region genes (Babcock et al., 1998).
In both cases, members of clones are mainly foundis mainly generated from EBV-infected naive B cells,
which subsequently underwent somatic hypermutation in proximity to each other. This may indicate that during
acute infection proliferating EBV-infected cells have lit-inside the GC. However, besides direct infection of
memory B cells, EBV may infect GC B cells that have tle tendency to migrate, although it is quite possible that
members of these clones still migrate out of the tonsil.already acquired somatic mutations. It may also cause a
shut down of the hypermutation activity in these infected At least for LMP1-positive cells, the clustering of clonally
related cells might be due to LMP1-induced upregula-cells. That EBV infection might indeed interfere with
the GC reaction is indicated by the finding that LMP1 tion of adhesion molecules (Wang et al., 1990). The frac-
tion of cells assigned to clones differs between the twoexpression blocked GC formation in a transgenic mouse
(Uchida et al., 1999). The possible direct infection of GC cases analyzed. This could be due to the fact that, in
case 2, tonsillectomy was performed later in the courseB cells is supported by the findings that the average
R/S value of EBV-infected cells in IM is in between the of the disease. Thus, since the T cell response was
longer lasting in this case compared to case 1, it isaverage R/S value of selected memory B cells and GC
cells and that in IM rare EBV-bearing cells are sometimes possible that the majority of EBV-infected cells has been
eliminiated by cytotoxic T cells, so that the pool of EBV-observed inside GCs (Anagnostopoulos et al., 1995; Nie-
dobitek et al., 1997a; Araujo et al., 1999; unpublished bearing cells is likely mainly formed by newly infected
cells. In line with this idea, most EBV-infected cells (ap-data). As pointed out above, this possibility is not contra-
dicted by the observation that the EBV-carrying cells proximately 90% of EBER-positive cells) in case 2 ex-
press EBNA2 but not LMP1, which is typical for cellsanalyzed were not located inside GCs since the follicular
structures of tonsils are usually disrupted during IM (Nie- early after infection (Alfieri et al., 1991). Alternatively, the
two cases may be infected by two distinct EBV variantsdobitek et al., 1992; Anagnostopoulos et al., 1995). In
that differ in their ability to induce B cell proliferationsummary, we think that in IM, unlike in virus persistence
(Rickinson et al., 1987).resulting from asymptomatic infection (and perhaps dis-
tinct from the events that take place during the first days
after infection and that result in IM), the pool of EBV- Variation in Morphology (and Gene Expression
Pattern) among Clonally Related EBV-Infected Cellsharboring cells with somatically mutated V region genes
results from direct infection of memory cells and likely We show that morphologically distinct, EBV-harboring
cells of IM, namely small- to medium-sized EBV-infectedalso of GC B cells. Differences in the behavior or load
of the virus or in the strength of the EBV-specific T cell cells and HRS-like cells, do not represent distinct sub-
sets in terms of their cellular derivation, since they canresponse could be the reason for the different pathways
of EBV dissemination in IM compared to virus persis- be members of the same clone. Moreover, members
of clones most likely also differ in terms of EBV genetence, which becomes also evident by the finding that
EBNA2-positive cells of IM are mostly GC and/or mem- expression patterns. This speculation is based on the
observation that HRS-like cells mostly show a latencyory B cells, whereas only naive IgD1 B cells express
EBNA2 during latency (Babcock et al., 2000). II expression pattern, whereas small- to medium-sized
EBV-infected cells are mainly in latency I or III (see
above). Switches in EBV gene expression programsThe Pool of EBV-Infected Cells is to a Great Extent
among members of clones have also been shown forFormed by Proliferation of EBV-Harboring
EBV1 lymphoblastoid and Burkitt’s cell lines in vitroMemory and/or GC B Cells
(Kieff, 1996; Szeles et al., 1999). In addition, the pheno-In both cases of IM analyzed here, clones of EBV-
typically different subtypes of EBV-infected cells ana-infected B cells were detected. Thus, the pool of EBV-
lyzed here are composed of comparable fractions ofcarrying cells is formed not only by infection of a large
naive and GC and/or memory B cells (Table 3). Thus, anumber of B cells, but also to a great extent by presum-
particular morphology and/or latency program of EBV-ably virus-driven proliferation of these cells. That expan-
encoded genes is not restricted to a special B cell differ-sion of EBV-carrying cells can be induced by EBV is
entiation stage.shown by in vitro studies demonstrating that B cells
transformed by the virus give rise to lymphoblastoid cell
lines (Diehl et al., 1969; Casali and Notkins, 1989), and Distinct Origin of HRS-Like Cells of IM
and HRS Cells of HDit is further indicated by the observation that LMP1 and
EBNA2 can induce B cell proliferation (Zimber-Strobl et HRS cells in classical HD generally carry mutated V
gene rearrangements and may survive without antigenal., 1996; Kilger et al., 1998).
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Figure 3. Scenario for the Generation of the
Pool of EBV-Infected Cells during IM and the
Establishment of a Lifelong Infection
Closed circles represent the EBV genome,
and open circles represent cells. The hori-
zontal lines indicate a V gene rearrangement;
vertical lines within the circles indicate so-
matic mutations. Although naive as well as
memory and/or GC B cells are infected,
expansion to large clones seems to be re-
stricted to the (post) GC B cell compartment.
It is unclear whether naive B cells can expand
to clones (implied by a question mark). The
relative distribution of naive and (post) GC B
cells with HRS-like morphology (indicated as
cells with irregular cell shape) shown in this
scheme does not mirror the situation found in
IM. Question marks indicate that it is unclear
whether HRS-like cells can persist after IM or
change their phenotype to small EBV-infected
cells. The possibility that HRS-like cells might
persist is implied by a patient who presented
with a B cell chronic lymphocytic leukemia
(B-CLL) and a clonal population of intermingled
HRS-like cells 2 years after diagnosis of IM (Kanzler et al., 2000). Since the HRS-like cells were clonally unrelated to the B-CLL, the HRS clone
might originate from an HRS-like cell of IM. Moreover, it is uncertain whether HRS-like cells can proliferate. Some EBV-harboring memory B
cells may survive after IM and build the initial pool of EBV-infected memory B cells of latent infection (Babcock et al., 1998). The lowercase
“a” indicates that members of clones can show distinct morphology, namely small- to medium-sized EBV-infected cells and HRS-like cells.
receptor expression, as indicated by the findings of ate a large pool of EBV-positive B cells (Figure 3): EBV
forms a large pool of virus-harboring cells by infectiondownregulation of immunoglobulin transcription and
“crippling” mutations such as nonsense mutations or of large numbers of naive as well as memory and GC B
cells (and perhaps other cells, such as T cells). Thedeletions resulting in loss of the correct reading frame
in approximately 30% of cases (Kanzler et al., 1996; population of EBV-carrying cells is further increased by
virus-driven B cell proliferation, which is largely re-Marafioti et al., 2000). In IM no obviously crippling muta-
tions were found in about 50 mutated in-frame V gene stricted to GC and/or memory B cells. Alternatively, it
is possible that EBV-bearing naive as well as GC and/rearrangements of HRS-like cells. Although it is possible
that HRS-like cells of IM may give rise to an HRS cell or memory B cells proliferate and that naive EBV-harbor-
ing B cells are preferentially eliminated by cytotoxic Tof HD, perhaps after reentering a GC and acquiring unfa-
vorable mutations, the present study shows that HRS- cells, which would result in the overrepresentation of GC
and/or memory B cells among expanding EBV-positivelike morphology is not directly correlated with the deriva-
tion from a “crippled” GC B cell. Cells with HRS-like cells. In the course of this clonal expansion, EBV-car-
rying cells can change their morphology and the expres-morphology must not have even been targeted by so-
matic hypermutation since cells with unmutated V genes sion pattern of EBV-encoded genes. B cells that become
resting and downregulate most EBV-encoded, immuno-were also found among HRS-like cells. Thus, it is still
unclear what determines HRS cell morphology. genic proteins can evade immune surveillance. Due to
the overrepesentation of memory and/or GC B cells
among EBV-bearing B cells (the latter cells may be in-The EBV Strategy during IM and in the Establishment
of a Lifelong Infection: A Scenario duced by EBV to differentiate into resting memory B
cell–like cells) and to the longevity of memory B cells,During persistence, EBV resides in the memory B cell
compartment in the peripheral blood (Babcock et al., it is likely that some EBV-infected memory B cells survive
after IM and establish the initial pool of EBV-harboring1998; Ehlin-Henriksson et al., 1999). In tonsils, however,
IgD1 B cells are also infected (Babcock et al., 1998). cells of persistence. The same scenario might also hold
true for asymptomatic primary infection, which may dif-Although it is not clear whether the EBV-infected IgD1
cells are indeed naive cells given that a fraction of IgD1 fer from IM simply by the number of cells involved.
B cells represents memory B cells (Klein et al., 1998b),
the following scenario has been proposed: EBV infects
Experimental Procedures
naive IgD1 B cells in the tonsils and induces the newly
infected cells to proliferate like lymphoblastoid cells in Tissue and Clinical Data
Tonsillectomies were perfomed in all six cases analyzed becausevitro. After downregulation of EBNA2, some of these
the patients developed IM complications. Patient 1 was a 15-year-naive EBV-bearing cells enter a GC reaction and later
old female with a 3 day history of IM. EBV serology confirmed thedifferentiate into memory B cells so that EBV gains ac-
diagnosis of IM (anti-VCA IgM and IgG). Patient 2 was a 15-year-cess to the memory B cell pool (Babcock et al., 2000). old female who presented with a more than 14 day history of ton-
Based on the present study, for the acute primary silitis. The diagnosis of IM was verified by EBV serology (anti-VCA
EBV infection an alternative scenario emerges for the IgM and IgG). The four additional cases of IM were analyzed by
immunohistochemistry and in situ hybridization. Two patients, onestrategy EBV has evolved to quickly and efficiently cre-
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18-year-old female and one 16-year-old male, had been symptom- sets of the respective J gene primers as described, with the following
atic about 3 days before surgery, and two males, 33 and 17-years modifications: (1) concentration of each primer in the first round is
old, had been symptomatic 14 and 17 days before tonsillectomy, 13.6 or 15 nM, (2) in the second round the annealing temperature
respectively. The diagnosis of IM was also confirmed by serology is 618C for all VH gene families (Kanzler et al., 1996; Braeuninger et
in these four cases. al., 1997; Ku¨ppers et al., 1997; Bra¨uninger et al., 1999; Kanzler et al.,
2000). Rearranged Vkgenes were not amplified since in l-expressing
Immunostaining, In Situ Hybridization, and Micromanipulation cells (nonfunctional) Vk gene rearrangements are usually inactivated
Immunostainings were performed on 7–10 mm thick frozen or paraf- and consequently unmutated (Klein et al., 1998a). Therefore, the
fin sections as described before (Ku¨ppers et al., 1997) by using amplification of Vk genes is less suitable for the analysis of a popula-
antibodies against CD30, LMP1, CD20 (BerH2, CS1–4, and L26: tion of cells in regard to the presence of somatic mutations in re-
DAKO, Hamburg, Germany), EBNA2 (Biotest, Dreieich, Germany), arranged V genes and thus a GC derivation. For some cells a frag-
CD3 (OKT3: Ortho Diagnostic Systems, Raritan, NJ; or polyclonal ment of the EBV-encoded EBNA1 gene was amplified in parallel.
rabbit anti-human CD3 antibody: DAKO) and T cell receptor b chain Thereto, two EBNA-specific primers (EBNA1F: 59-GGT CGC CGG
(bF1: T cell Science, Cambridge, MA). Secondary antibodies were TGT GTT CGT ATA TGG-39, EBNA1R1: 59-GCG GCA GCC CCT TCC
biotinylated and visualized by avidin – coupled either to alkaline ACC ATA G-39) were added to the primer mix of the first round. The
phosphatase or to horseradish peroxidase (DAKO). Fast red (DAKO) second round for the EBNA1 fragment was carried out in a separate
was used as a substrate for alkaline phosphatase, and DAB (Sigma- reaction with primers EBNA1F and EBNA1R2 (EBNA1R2: 59-AGG
Aldrich, Deisenhofen, Germany) served as a substrate for horserad- GAG GCA AAT CTA CTC CAT CGT C-39). The PCR program for the
ish peroxidase. EBNA1 fragment differed from the second round of the VH PCR only
For simultaneous staining of either LMP1 and EBNA2 or CD3 and by the number of cycles (35 cycles).
EBNA2 the fluorescent staining technique was applied by using The analysis of some CD301 HRS-like cells of the second case
FITC-conjugated goat anti-rat IgG antibodies (Santa Cruz Biotech- was performed using family-specific VH leader (L) (Braeuninger et
nology, CA) for the detection of EBNA21 cells and Alexa Fluor- al., 1997), Vl, Vk, and EBNA1 primers in the first round. In the second
coupled goat anti-mouse IgG antibodies (Molecular Probes, OR) or round, Vk gene rearrangements were not analyzed. The PCR was
Cy3-conjugated goat anti-rabbit IgG antibodies (Dianova, Hamburg, carried out as described for a combination of VHL, Vk, 39 JH, and 39
Germany) for the detection of LMP11 cells or CD31 cells, respec- Jk primers (Kanzler et al., 2000) with the following changes: (1) addi-
tively. The LMP1-specific stainings were performed by using two tion of Vl, 39 Jk, EBNA1F, and EBNA1R1 primers, (2) primer concen-
different anti-LMP1 antibodies (CS1–4, DAKO and S12, kindly sup- tration of 50 nM, and (3) 2 mM MgCl2 for VHL4.
plied by D. A. Thorley-Lawson) and gave comparable results. If a PEP reaction was performed (see above), the following modifi-
To detect EBV-infected cells, in situ hybridization was performed cations were introduced to the protocol of the first round: (1) the
with in vitro transcribed digoxygenin-labeled probes specific for gene-specific PCRs were carried out with 4 ml aliquots of these PEP
EBV-encoded small nuclear RNAs (EBER 1 and 2) (Niedobitek et reactions, (2) the reaction started with 10 min denaturation at 958C,
al., 1991). In situ hybridization was performed on paraffin sections as (3) separate first rounds for VH/EBNA1 and Vl were carried out, andpreviously described (Kanzler et al., 2000). When in situ hybridization
(4) 13 Promega PCR buffer and 2.5 U Promega Taq DNA polymerase
was carried out on frozen sections, the following modifications were
in storage buffer A (Promega) were used.
introduced: before fixation in 4% paraformaldehyde and dehydra-
PCR products were gel purified and sequenced on an ABI 377
tion, sections were heated to 918C–958C for 3 min, fixed in 4%
sequencer (PE Applied Biosystems, Weiterstadt, Germany). Se-paraformaldehyde and treated with 0.5 mg/ml of Pronase (Boeh-
quence analysis was performed using DNASIS software (Pharmacia,ringer Mannheim, Mannheim, Germany). BCIP/NBT, BCIP/NBT/INT,
Freiburg, Germany) and the V-BASE database (http://www.mrc-or fast red (DAKO) served as staining substrates.
cpe.cam.ac.uk/imt-doc/restricted/DNAPLOT.html).To distinguish HRS-like cells from other EBV-infected cells, a
combination of CD30 immunostaining and EBER in situ hybridization
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